Key Finding
The ATP-P2X7-NLRP3 signaling axis represents a shared molecular mechanism driving cell death and chronic inflammation in both degenerative bone diseases and cardiovascular diseases, suggesting common therapeutic targets across these conditions.
Researchers have identified a common mechanism that may explain how both degenerative bone diseases and heart problems develop and progress. This study examined how ATP, a molecule your body uses for energy, can actually trigger harmful inflammation and cell death when it accumulates outside of cells. The researchers found that excess ATP activates a specific pathway (called ATP-P2X7-NLRP3) that leads to inflammation and cell death in conditions like osteoarthritis, disc degeneration, osteoporosis, heart attacks, and heart failure. When ATP binds to a receptor called P2X7, it sets off a chain reaction involving calcium flooding into cells, mitochondrial damage, oxidative stress, and activation of inflammatory proteins. This ultimately causes different types of cell death including pyroptosis, apoptosis, and ferroptosis. The findings suggest that chronic inflammation and energy imbalance are central to both bone and heart diseases. For patients considering acupuncture, this research is relevant because acupuncture has been shown in other studies to modulate ATP signaling, reduce inflammation, and potentially influence mitochondrial function. The anti-inflammatory effects of acupuncture may work through some of these same molecular pathways, potentially offering therapeutic benefits for conditions involving the ATP-P2X7-NLRP3 axis. This suggests acupuncture could be a complementary approach for managing inflammatory aspects of osteoarthritis, chronic pain, and possibly cardiovascular conditions, though more research is needed to confirm these connections. Patients interested in acupuncture for these conditions should seek treatment from a licensed acupuncturist with appropriate training and credentials.
This review article examines the ATP-P2X7-NLRP3 signaling axis as a unifying pathological mechanism in degenerative bone diseases (osteoarthritis, intervertebral disc degeneration, osteoporosis) and cardiovascular diseases (myocardial infarction, heart failure). The authors describe how extracellular ATP functions as a damage-associated molecular pattern (DAMP), activating P2X7 purinergic receptors and triggering NLRP3 inflammasome activation. This cascade induces calcium influx, mitochondrial dysfunction, oxidative stress, and multiple forms of programmed cell death (pyroptosis, apoptosis, ferroptosis). The review synthesizes experimental and clinical evidence demonstrating this pathway's role in chronic inflammation and energy dysregulation across both disease categories. Clinical implications include potential therapeutic targeting of the ATP-purinergic-mitochondrial axis through P2X7 antagonists, NLRP3 inhibitors, or interventions modulating ATP metabolism. For acupuncture practitioners, this mechanism may partially explain acupuncture's anti-inflammatory effects in osteoarthritis and chronic pain, as needling has been shown to influence purinergic signaling and reduce inflammatory cytokines. The shared pathophysiology suggests integrated treatment approaches addressing inflammation and cellular energy metabolism may benefit multiple degenerative conditions simultaneously.
Browse our directory of verified licensed practitioners near you.
Find a practitioner โ๐ Among patients with moderate-to-severe chronic pain, depression, anxiety, and sleep disturbance affect 36.6%, 19.1%, and 46.3% respectively, with pain interference and alcohol consumption emerging as modifiable factors associated with multiple psychological comorbidities.
๐ An integrated treatment approach combining acupotomy at trigger points, specific acupuncture point combinations targeting wind dispersion, herbal medicine, and bloodletting may provide holistic management of primary trigeminal neuralgia according to one expert's clinical experience.
๐ Eight Constitution Medicine significantly improved pain scores and quality of life in musculoskeletal pain patients, with particular effectiveness for low back pain and knee osteoarthritis, and no reported adverse events.